The relationship between relapse, impairment and disability in multiple sclerosis

Multiple Sclerosis Journal

Volumn 17, Issue 10, 2011, Pages 1218-1224

  Bennetto, L ^a   Burrow, J ^a   Sakai, H ^b   Cobby, J ^b   Robertson, N P ^c   Scolding, N ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

all demyelinating disease (CNS); multiple sclerosis; multiple sclerosis disability; multiple sclerosis relapse; natural history studies (prognosis); optic neuritis

Indexed keywords

ADULT; ARTICLE; DEMYELINATING DISEASE; DISABILITY; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPTIC NEURITIS; PATIENT MOBILITY; RELAPSE; SCORING SYSTEM;

EID: 80053594178     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511407368     Document Type: Article

References (26)

1. Ebers GC. Disease evolution in multiple sclerosis. J Neurol. 2006 ; 253 (Suppl. 6). vi3 - vi8
2. Cottrell DA, Kremenchutzky M, Rice GP, Koopman WJ, Hader W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain. 1999 ; 122: 625-639 (Pubitemid 29158771)
3. DeLuca GC, Williams K, Evangelou N, Ebers GC, Esiri MM. The contribution of demyelination to axonal loss in multiple sclerosis. Brain. 2006 ;: awl074 - awl074
4. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989 ; 112: 133-146 (Pubitemid 19056478)
5. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000 ; 343: 1430-1438
6. Bejaoui K, Rolak LA. What is the risk of permanent disability from a multiple sclerosis relapse?. Neurology. 2010 ; 74: 900-902
7. Kremenchutzky M, Cottrell D, Rice G, Hader W, Baskerville J, Koopman W, Ebers GC. The natural history of multiple sclerosis: a geographically based study: 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain. 1999 ; 122: 1941-1950
8. Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain. 2006 ; 129: 584-594 (Pubitemid 43278221)
9. Muller R. Studies on disseminated sclerosis with special reference to symptomatology, course and prognosis. Acta Med Scand. 1949 ; 133: 1-214
10. Ebers GC, Traboulsee A, Li D, Langdon D, Reder AT, Goodin DS, et al. Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial. J Neurol Neurosurg Psychiatry. 2010 ; 81: 907-912
11. Lublin FD, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology. 2003 ; 61: 1528-1532 (Pubitemid 37505574)
12. Hirst C, Ingram G, Pearson O, Pickersgill T, Scolding N, Robertson N. Contribution of relapses to disability in multiple sclerosis. J Neurol. 2008 ; 255: 280-287
13. Vercellino M, Romagnolo A, Mattioda A, Masera S, Piacentino C, Merola A, et al. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants. Acta Neurol Scand. 2009 ; 119: 126-130
14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
15. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 ; 46: 907-911
16. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 ; 13: 227-231 (Pubitemid 13158528)
17. Ebers GC. Natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001 ; 71 (Suppl. 2). ii16 - ii19
18. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993 ; 116: 117-134 (Pubitemid 23087038)
19. Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, Ebers GC. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain. 2010 ; 133: 1914-1929
20. Tremlett H, Yousefi M, Devonshire V, Rieckmann P, Zhao Y. Impact of multiple sclerosis relapses on progression diminishes with time. Neurology. 2009 ; 73: 1616-1623
21. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain. 2001 ; 124: 1813-1820 (Pubitemid 32845442)
22. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain. 2003 ; 126: 770-782 (Pubitemid 36372978)
23. Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain. 2006 ; 129: 606-616 (Pubitemid 43278223)
24. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
25. Sipe JC, Knobler RL, Braheny SL, Rice GP, Panitch HS, Oldstone MB. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology. 1984 ; 34: 1368-1372 (Pubitemid 14047252)
26. Patani R, Balaratnam M, Vora A, Reynolds R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol. 2007 ; 33: 277-287 (Pubitemid 46701044)